Related Experiment Video
Updated: Apr 19, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Facilitators and barriers of medication adherence in pediatric liver and kidney transplant recipients: a
Anouck Claes1, Anneloes Decorte2, Elena Levtchenko2
1University of Leuven, Leuven, Belgium.
Insights
Pediatric transplant patients face medication adherence challenges. Practical aids and fewer regimen changes significantly improve adherence for young transplant recipients.
Area of Science:
- Pediatric Transplant Medicine
- Pharmacology
- Patient Adherence Research
Background:
- Young transplant patients (≤11 years) often struggle with adhering to immunosuppressive and co-medications.
- Existing research on adherence determinants in this age group is limited, flawed, and often focuses narrowly on barriers.
Purpose of the Study:
- To identify factors that positively and negatively affect medication adherence in pediatric transplant recipients.
- To explore facilitators and barriers to medication adherence from parental perspectives.
Main Methods:
- A consecutive mixed-methods design combining qualitative interviews and quantitative adherence assessment.
- Semistructured interviews with parents of 10 pediatric liver or kidney transplant recipients (2-11 years old).
- Adherence quantification and use of the "immunosuppressive medication adherence barriers" self-report instrument.
Main Results:
- Common barriers included forgetfulness (70%), vomiting (70%), bad taste (60%), and routine interruptions (60%).
- Key facilitators reported by parents were practical aids (100%), always carrying medication (100%), fewer medications (80%), and stable regimens (80%).
- No significant distinction in barriers or facilitators was found between immunosuppressants and co-medications.
Conclusions:
- Peer experiences offer valuable insights for improving medication adherence in young transplant patients.
- Practical strategies and regimen simplification are crucial for enhancing adherence in this population.
Objective:
Many young transplant patients (≤11 years old) struggle to take their immunosuppressive and co-medications correctly, yet it remains unclear which factors positively or negatively affect medication adherence. Research studies on determinants in this age group are scarce, have methodological flaws, and focus exclusively on immunosuppressants or on barriers rather than on facilitators.
Methods:
This study used a consecutive mixed-methods (qualitative + quantitative) design. Semistructured interviews with parents of 10 pediatric liver or kidney transplant recipients 2 to 11 years old on adherence facilitators and barriers were conducted, complemented by quantification of adherence to the immunosuppressants and co-medications, and completion of the "immunosuppressive medication adherence barriers" self-report instrument.
Results:
A median of 19 (range, 10-29) barriers was reported: the most commonly encountered were forgetfulness (70%), vomiting (70%), bad taste (60%), and interruptions in routine (60%). Parents reported a median of 15 facilitators (range, 6-26), including using practical aids (100%), having medication with you at all times (100%), having to take fewer medications (80%), and experiencing fewer regimen changes over time (80%). No clear distinction between immunosuppressants or co-medications was made.
Conclusions:
This study provides several new insights based on peer experience to support future patients and their parents in medication adherence.
Related Concept Videos
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Pharmacokinetics in Pediatric Patients: Drug Excretion
Kidney Transplant II: Surgical Procedure
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

